LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
24.25
+0.47 (1.98%)
Mar 9, 2026, 3:54 PM EDT - Market open
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $613.50 million as of March 9, 2026.
Market Cap
613.50M
Enterprise Value
298.64M
1-Year Change
n/a
Ranking
Category
Stock Price
$24.25
Market Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $613.50M, an increase of 103.48%. That is a compound annual growth rate of 336.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 601.61M | 6.83% |
| Dec 31, 2025 | 563.16M | 86.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zura Bio | 657.49M |
| Alto Neuroscience | 652.39M |
| Jade Biosciences | 644.06M |
| Vor Biopharma | 625.29M |
| enGene Holdings | 584.15M |
| Design Therapeutics | 574.19M |
| YD Bio | 573.11M |
| Larimar Therapeutics | 565.76M |